Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prokidney Corp (PROK)

Prokidney Corp (PROK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 530,105
  • Shares Outstanding, K 289,675
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,470 K
  • EBIT $ -154 M
  • EBITDA $ -150 M
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 204.86% ( -146.40%)
  • Historical Volatility 96.32%
  • IV Percentile 57%
  • IV Rank 21.11%
  • IV High 917.73% on 12/18/23
  • IV Low 14.08% on 07/15/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 119
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 2,866
  • Open Int (30-Day) 5,056

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 4
  • High Estimate -0.09
  • Low Estimate -0.18
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4900 +27.18%
on 11/04/24
2.0300 -6.65%
on 10/17/24
+0.3400 (+21.86%)
since 10/07/24
3-Month
1.4801 +28.03%
on 10/03/24
2.5700 -26.26%
on 09/19/24
+0.0650 (+3.55%)
since 08/07/24
52-Week
1.1200 +69.20%
on 11/17/23
4.4400 -57.32%
on 05/20/24
+0.2850 (+17.70%)
since 11/07/23

Most Recent Stories

More News
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

PROK : 1.9300 (+5.46%)
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024

PROK : 1.9300 (+5.46%)
ProKidney to Participate in the UBS Virtual Organ Restoration Day

PROK : 1.9300 (+5.46%)
Why Shares of ProKidney Were Dropping Thursday

Two factors led to the stock's slide on Thursday.

PROK : 1.9300 (+5.46%)
Pre-Market Brief: Stocks Mostly Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.32% this morning after three major U.S. benchmark indices finished the regular session higher as market participants awaited U.S. inflation data for further...

ESH23 : 3,957.05s (-0.09%)
JD-.LN : 124.000 (+0.85%)
HEPA : 0.6401 (-0.14%)
BWEN : 1.8600 (+1.92%)
PROK : 1.9300 (+5.46%)
CONN : 0.0975 (-46.40%)
SHC : 15.83 (-1.74%)
STM : 27.13 (+2.38%)
Did This News Just Mark the End of the SPAC Boom?

The most prolific SPAC sponsor just made a big announcement.

LCID : 2.21 (+3.87%)
DKNG : 38.98 (+1.90%)
SPCE : 6.28 (-11.80%)
OPEN : 1.8700 (+5.06%)
CLOV : 3.67 (-15.63%)
SOFI : 11.90 (+0.76%)
PROK : 1.9300 (+5.46%)
AKLI : 0.4320 (-0.62%)
IPOD : 10.03 (-0.10%)
IPOF : 10.03 (unch)
ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox

Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins...

PROK : 1.9300 (+5.46%)
ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs

Extensive Nephrology Medical Affairs Leadership and Clinical Practice Expertise Brought to ProKidney...

PROK : 1.9300 (+5.46%)

Business Summary

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM,...

See More

Key Turning Points

3rd Resistance Point 2.1300
2nd Resistance Point 1.9900
1st Resistance Point 1.9100
Last Price 1.9300
1st Support Level 1.6900
2nd Support Level 1.5500
3rd Support Level 1.4700

See More

52-Week High 4.4400
Fibonacci 61.8% 3.1718
Fibonacci 50% 2.7800
Fibonacci 38.2% 2.3882
Last Price 1.9300
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar